Evidence map›Paper›PMID 42536061›Full record

ArticleMicrobial genomics2026

Phylogenetic analysis of serotype 19A-sequence type (ST)2331

Shota Koide, Satoshi Nakano, Takao Fujisawa, Yutaka Ito, Bin Chang, Shigeru Suga, Yo Sugawara, Yukihiro Akeda, Motoyuki Sugai

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbial genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Shota KoideAntimicrobial Resistance Research Center, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan.
Satoshi NakanoAntimicrobial Resistance Research Center, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan.
Takao FujisawaNational Hospital Organization, Mie National Hospital, Tsu, Japan.
Yutaka ItoNagoya City University, Graduate School of Medical Science, Nagoya, Japan.
Bin ChangDepartment of Bacteriology I, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan.
Shigeru SugaNational Hospital Organization, Mie National Hospital, Tsu, Japan.
Yo SugawaraAntimicrobial Resistance Research Center, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan.
Yukihiro AkedaDepartment of Bacteriology I, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan.
Motoyuki SugaiAntimicrobial Resistance Research Center, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Following the introduction of the 7-valent pneumococcal conjugate vaccine (PCV7), serotype 19A

Indexed as

Heptavalent Pneumococcal Conjugate VaccinePhylogenyPneumococcal InfectionsStreptococcus pneumoniaeAnti-Bacterial AgentsDrug Resistance, Multiple, BacterialGenome, BacterialHumansJapanMolecular EpidemiologyPneumococcal VaccinesSerogroupWhole Genome SequencingAnti-Bacterial AgentsHeptavalent Pneumococcal Conjugate VaccinePneumococcal VaccinesGPSC32PMEN34pneumococcal conjugate vaccineserotype 19AST2331Streptococcus pneumoniaewhole-genome sequencing

Identifiers

PMID42536061
PMCPMC13426510

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.